Investors

Investors arrow Analyst Coverage
Print E-mail
Analyst Coverage

Firm Analyst
Crystal Research Associates, LLC   Jeffrey J. Kraws/Karen B. Goldfarb
LifeTech Capital   Stephen M. Dunn
McNicoll, Lewis & Vlak LLC.   George B. Zavoico, Ph.D.
ROTH Capital Partners   Joseph Pantginis, Ph.D.

Peregrine Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Peregrine Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Peregrine Pharmaceuticals, Inc. or its management. Peregrine Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. The above may not represent a comprehensive list of analysts choosing to cover Peregrine Pharmaceuticals, Inc.

Stock Information  
NASDAQ:PPHM
$1.42   + 0.08
Sep 9, 2010
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Shareholder Tools  
 
 
© 2003/2010 Peregrine Pharmaceuticals Inc., All Rights Reserved   Disclaimer | Safe Harbor